ArticleEndocrinology and metabolism (Seoul, Korea)2014

Accelerated disease progression after discontinuation of sorafenib in a patient with metastatic papillary thyroid cancer.

Kyung-Jin Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.